First Tracks Biotherapeutics, Inc.
TRAX
$15.97
$0.221.40%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -50.48M | -47.20M | |||
| Total Depreciation and Amortization | 125.00K | 606.00K | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 11.50M | 6.08M | |||
| Change in Net Operating Assets | 6.30M | -4.50M | |||
| Cash from Operations | -32.56M | -45.01M | |||
| Capital Expenditure | -17.00K | -35.00K | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | 35.00M | 14.88M | |||
| Cash from Investing | 34.98M | 14.85M | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 7.85M | 5.72M | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | 7.85M | 5.72M | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 10.27M | -24.44M | |||